HIF prolyl hydroxylase 2/3 deletion disrupts astrocytic integrity and exacerbates neuroinflammation

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Kamil Sebastian Rosiewicz - , Experimental and Clinical Research Center (ECRC) (Autor:in)
  • Bakhrom Muinjonov - , Experimental and Clinical Research Center (ECRC) (Autor:in)
  • Séverine Kunz - , Technology Platform for Electron Microscopy (Autor:in)
  • Helena Radbruch - , Universität Zürich (Autor:in)
  • Jessy Chen - , Experimental and Clinical Research Center (ECRC) (Autor:in)
  • René Jüttner - , Max-Delbrück-Centrum für Molekulare Medizin (MDC) (Autor:in)
  • Janis Kerkering - , Experimental and Clinical Research Center (ECRC) (Autor:in)
  • Julia Ucar - , Experimental and Clinical Research Center (ECRC) (Autor:in)
  • Tadhg Crowley - , Experimental and Clinical Research Center (ECRC) (Autor:in)
  • Ben Wielockx - , Institut für Klinische Chemie und Laboratoriumsmedizin (Autor:in)
  • Friedemann Paul - , Experimental and Clinical Research Center (ECRC) (Autor:in)
  • Marlen Alisch - , Experimental and Clinical Research Center (ECRC) (Autor:in)
  • Volker Siffrin - , Experimental and Clinical Research Center (ECRC) (Autor:in)

Abstract

Astrocytes constitute the parenchymal border of the blood-brain barrier (BBB), modulate the exchange of soluble and cellular elements, and are essential for neuronal metabolic support. Thus, astrocytes critically influence neuronal network integrity. In hypoxia, astrocytes upregulate a transcriptional program that has been shown to boost neuroprotection in several models of neurological diseases. We investigated transgenic mice with astrocyte-specific activation of the hypoxia-response program by deleting the oxygen sensors, HIF prolyl-hydroxylase domains 2 and 3 (Phd2/3). We induced astrocytic Phd2/3 deletion after onset of clinical signs in experimental autoimmune encephalomyelitis (EAE) that led to an exacerbation of the disease mediated by massive immune cell infiltration. We found that Phd2/3-ko astrocytes, though expressing a neuroprotective signature, exhibited a gradual loss of gap-junctional Connexin-43 (Cx43), which was induced by vascular endothelial growth factor-alpha (Vegf-a) expression. These results provide mechanistic insights into astrocyte biology, their critical role in hypoxic states, and in chronic inflammatory CNS diseases.

Details

OriginalspracheEnglisch
Seiten (von - bis)2024-2044
Seitenumfang21
FachzeitschriftGLIA
Jahrgang71
Ausgabenummer8
PublikationsstatusVeröffentlicht - Aug. 2023
Peer-Review-StatusJa

Externe IDs

Scopus 85158014334

Schlagworte

Schlagwörter

  • Animals, Astrocytes/metabolism, Encephalomyelitis, Autoimmune, Experimental/genetics, Hypoxia-Inducible Factor 1, alpha Subunit/genetics, Hypoxia-Inducible Factor-Proline Dioxygenases/genetics, Hypoxia/metabolism, Mice, Neuroinflammatory Diseases, Procollagen-Proline Dioxygenase/metabolism, Prolyl Hydroxylases/metabolism, Vascular Endothelial Growth Factor A/genetics